We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M Turnover 15.36%
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
3.5 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.2 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.2 years

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PGZ icon
251
Principal Real Estate Income Fund
PGZ
$58.4M
$126K 0.03%
11,278
+344
+3% +$3.69K
2016 Q4
31 quarters
CMPS icon
252
Compass Pathways
CMPS
$1.56B
$63.6K 0.02%
10,100
– –
2024 Q1
2 quarters
IRLA
253
IRulya Therapeutics Inc. Common Stock
IRLA
$30.5M
$41.5K 0.01%
268
+1
+0.4% +$143
2023 Q2
5 quarters
NCV icon
254
Virtus Convertible & Income Fund
NCV
$340M
$38K 0.01%
2,713
+80
+3% +$1.09K
2024 Q2
1 quarter
PRTS icon
255
CarParts.com
PRTS
$58M
$33.8K 0.01%
3,725
-450
-11% -$4.25K
2020 Q4
15 quarters
PLUG icon
256
Plug Power
PLUG
$2.03B
$25.8K 0.01%
11,400
– –
2023 Q2
5 quarters
PXSAW
257
DELISTED
Pyxis Tankers Inc Warrant
PXSAW
$20.6K 0.01%
24,000
– –
2024 Q1
2 quarters
NKTR icon
258
Nektar Therapeutics
NKTR
$1.26B
$13K ﹤0.01%
667
– –
2024 Q2
1 quarter
CBIO icon
259
Crescent Biopharma
CBIO
$467M
$7.77K ﹤0.01%
460
– –
2020 Q4
15 quarters
MBLY icon
260
CALL
Mobileye
MBLY
$6.08B
$6.6K ﹤0.01%
+12,000
New +$210K
2024 Q3
0 quarters
TBLAW icon
261
DELISTED
Taboola.com Ltd Warrant
TBLAW
$5K ﹤0.01%
38,500
+15,000
+64% +$1.75K
2024 Q1
2 quarters
NUVB.WS icon
262
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$2.19K ﹤0.01%
+22,396
New +$3.92K
2024 Q3
0 quarters
BKSY.WS icon
263
DELISTED
BlackSky Technology Inc Warrants
BKSY.WS
$1.1K ﹤0.01%
+35,994
New +$1.28K
2024 Q3
0 quarters
MNTSW icon
264
DELISTED
Momentus Inc Warrant
MNTSW
$330 ﹤0.01%
34,199
-755
-2% -$7
2024 Q1
2 quarters
AMGN icon
265
Amgen
AMGN
$230B
– –
-4,126
Closed -$1.29M –
ASAN icon
266
Asana
ASAN
$2.25B
– –
-14,250
Closed -$199K –
BIIB icon
267
Biogen
BIIB
$34.4B
– –
-6,029
Closed -$1.4M –
CARR icon
268
Carrier Global
CARR
$44.7B
– –
-12,540
Closed -$793K –
CHKP icon
269
Check Point Software Technologies
CHKP
$13.7B
– –
-1,500
Closed -$248K –
CIBR icon
270
First Trust NASDAQ Cybersecurity ETF
CIBR
$18B
– –
-3,562
Closed -$201K –
CL icon
271
Colgate-Palmolive
CL
$74B
– –
-6,657
Closed -$646K –
HL icon
272
Hecla Mining
HL
$10B
– –
-16,510
Closed -$80.1K –
KO icon
273
Coca-Cola
KO
$395B
– –
-13,503
Closed -$866K –
MLKN icon
274
MillerKnoll
MLKN
$1.45B
– –
-8,796
Closed -$235K –
NUE icon
275
Nucor
NUE
$58.3B
– –
-4,948
Closed -$785K –

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.